The Interaction of Body Mass Index and Race in Predicting Biochemical Failure After Radical Prostatectomy

Overview

Journal BJU Int

Specialty Urology

Date 2010 Oct 15

PMID 20942835

Citations 1

Authors

Daniel J Lee

Chad Ritch

Manisha Desai

Mitchell C Benson

James M McKiernan

Affiliations

Soon will be listed here.

Abstract

Study Type: Therapy (case series).

Level Of Evidence: 4

Objective: To examine the interaction of body mass index (BMI) and race in predicting biochemical failure (BCF) after radical prostatectomy (RP). The relative contribution of BMI and race to BCF after RP has not been well characterized.

Patients And Methods: From 1988 to 2008, 969 white and black men underwent RP and BMI data were available. In all, 168 (17.3%) were black and 801 (82.7%) were white men. BCF was defined as a post-surgery PSA level≥0.2 ng/mL on ≥2 measurements. Cox regression methods were used to model the relationship between race, BMI and BCF.

Results: The 969 men had a mean age of 59.8±7.2 years. There was no significant difference in BMI between black and white men (P=0.32). The 5-year disease-free survival for black obese men was the lowest at 48%, compared with non-obese black (73%), obese white (82%) and non-obese white men (83%, P<0.001). BMI did not have a significant impact on BCF. In a multivariate analysis, black race remained an independent predictor of BCF [hazard ratio (HR)=1.76, P=0.01]. BMI does not affect the risk of BCF in black men differently than white men (P value for interaction 0.93).

Conclusions: Black race is an independent predictor of biochemical failure after adjusting for pathological factors. The impact of BMI on BCF did not vary among different races. These findings suggest that elevated BMI does not affect the BCF rates of black men more than in other races, and that other factors may influence the racial variability in disease-free survival and BCF risk.

Citing Articles

Race-specific prostate cancer outcomes in a cohort of military health care beneficiaries undergoing surgery: 1990-2017.

Oehrlein N, Streicher S, Kuo H, Chaurasia A, McFadden J, Nousome D Cancer Med. 2022; 11(22):4354-4365.

PMID: 35638719 PMC: 9678085. DOI: 10.1002/cam4.4787.

References

Grossfeld G, Latini D, Downs T, Lubeck D, Mehta S, Carroll P . Is ethnicity an independent predictor of prostate cancer recurrence after radical prostatectomy?. J Urol. 2002; 168(6):2510-5. DOI: 10.1016/S0022-5347(05)64179-1. View

Andersson S, Wolk A, Bergstrom R, Adami H, Engholm G, Englund A . Body size and prostate cancer: a 20-year follow-up study among 135006 Swedish construction workers. J Natl Cancer Inst. 1997; 89(5):385-9. DOI: 10.1093/jnci/89.5.385. View

Spangler E, Zeigler-Johnson C, Coomes M, Malkowicz S, Wein A, Rebbeck T . Association of obesity with tumor characteristics and treatment failure of prostate cancer in African-American and European American men. J Urol. 2007; 178(5):1939-44. DOI: 10.1016/j.juro.2007.07.021. View

MORTON Jr R . Racial differences in adenocarcinoma of the prostate in North American men. Urology. 1994; 44(5):637-45. DOI: 10.1016/s0090-4295(94)80196-7. View

Hayes R, Ziegler R, Gridley G, Swanson C, Greenberg R, Swanson G . Dietary factors and risks for prostate cancer among blacks and whites in the United States. Cancer Epidemiol Biomarkers Prev. 1999; 8(1):25-34. View

Optenberg S, Thompson I, Friedrichs P, Wojcik B, Stein C, Kramer B . Race, treatment, and long-term survival from prostate cancer in an equal-access medical care delivery system. JAMA. 1995; 274(20):1599-605. View

Ogden C, Carroll M, Curtin L, McDowell M, Tabak C, Flegal K . Prevalence of overweight and obesity in the United States, 1999-2004. JAMA. 2006; 295(13):1549-55. DOI: 10.1001/jama.295.13.1549. View

Amling C, Riffenburgh R, Sun L, Moul J, Lance R, Kusuda L . Pathologic variables and recurrence rates as related to obesity and race in men with prostate cancer undergoing radical prostatectomy. J Clin Oncol. 2003; 22(3):439-45. DOI: 10.1200/JCO.2004.03.132. View

Rodriguez C, Patel A, Calle E, Jacobs E, Chao A, Thun M . Body mass index, height, and prostate cancer mortality in two large cohorts of adult men in the United States. Cancer Epidemiol Biomarkers Prev. 2001; 10(4):345-53. View

10.

Nielsen M, Han M, Mangold L, Humphreys E, Walsh P, Partin A . Black race does not independently predict adverse outcome following radical retropubic prostatectomy at a tertiary referral center. J Urol. 2006; 176(2):515-9. DOI: 10.1016/j.juro.2006.03.100. View

11.

Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T . Cancer statistics, 2008. CA Cancer J Clin. 2008; 58(2):71-96. DOI: 10.3322/CA.2007.0010. View

12.

Hoffman R, Gilliland F, Eley J, Harlan L, Stephenson R, Stanford J . Racial and ethnic differences in advanced-stage prostate cancer: the Prostate Cancer Outcomes Study. J Natl Cancer Inst. 2001; 93(5):388-95. DOI: 10.1093/jnci/93.5.388. View

13.

Chun F, Briganti A, Graefen M, Erbersdobler A, Walz J, Schlomm T . Body mass index does not improve the ability to predict biochemical recurrence after radical prostatectomy. Eur J Cancer. 2006; 43(2):375-82. DOI: 10.1016/j.ejca.2006.08.037. View

14.

Maiti B, Kundranda M, Spiro T, Daw H . The association of metabolic syndrome with triple-negative breast cancer. Breast Cancer Res Treat. 2009; 121(2):479-83. DOI: 10.1007/s10549-009-0591-y. View

15.

Calle E, Rodriguez C, Walker-Thurmond K, Thun M . Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med. 2003; 348(17):1625-38. DOI: 10.1056/NEJMoa021423. View

16.

Moul J, Douglas T, McCarthy W, McLeod D . Black race is an adverse prognostic factor for prostate cancer recurrence following radical prostatectomy in an equal access health care setting. J Urol. 1996; 155(5):1667-73. View

17.

Powell I, Dey J, Dudley A, Pontes J, Cher M, Sakr W . Disease-free survival difference between African Americans and whites after radical prostatectomy for local prostate cancer: a multivariable analysis. Urology. 2002; 59(6):907-12. DOI: 10.1016/s0090-4295(02)01609-6. View

18.

Banez L, Hamilton R, Partin A, Vollmer R, Sun L, Rodriguez C . Obesity-related plasma hemodilution and PSA concentration among men with prostate cancer. JAMA. 2007; 298(19):2275-80. DOI: 10.1001/jama.298.19.2275. View

19.

Ghafoor A, Jemal A, Cokkinides V, Cardinez C, Murray T, Samuels A . Cancer statistics for African Americans. CA Cancer J Clin. 2002; 52(6):326-41. DOI: 10.3322/canjclin.52.6.326. View

20.

Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun M . Cancer statistics, 2009. CA Cancer J Clin. 2009; 59(4):225-49. DOI: 10.3322/caac.20006. View